Long-Term Outcomes Assessment

Author(s):

Davida Kruger, MSN, APN-BC, BC-ADM ,Jaime Murillo, MD, FACC, FASE

Experts share specific examples of how continuous glucose monitoring (CGM) technology has impacted diabetes-related health care costs and quality performance metrics, and discuss the methods used to measure and track CGM's long-term impact on diabetes complications, associated costs, and quality outcomes.

EP: 1.CGM: Redefining Type 2 Diabetes Management

EP: 2.Key Benefits of CGM Technology

EP: 3.CGM's Impact on Clinical Inertia

EP: 4.CGM vs Traditional Monitoring

EP: 5.Understanding CGM Metrics

EP: 6.Health Care System Integration

EP: 7.CGM Coverage and Access

EP: 8.Implementation Barriers

EP: 9.Overcoming Access Challenges

EP: 10.Adoption Strategies

EP: 11.The Metro Nashville Public Schools Initiative

EP: 12.Health Care Quality Impact

EP: 13.Population Outcomes and Return on Value With CGMs

Now Viewing

EP: 14.Long-Term Outcomes Assessment

EP: 15.Closing Perspectives

Video content above is prompted by the following:

Please share specific examples of how CGM technology has impacted diabetes-related healthcare costs and quality performance metrics.
What methods do you use to measure and track CGM's long-term impact on diabetes complications, associated costs, and quality outcomes?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!